IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
https://doi.org/10.22627/2072-8107-2018-17-2-34-39
Abstract
The objective — to characterize the effectiveness of different schemes of antiretroviral therapy in children with HIV infection and on the basis of the obtained data to improve of the disease treatment.
Patients and Methods: A clinical, immunological and virological examination of 45 children with HIV infection were carried. Patients received antiretroviral therapy — abacavire and lamivudine in combination with lopinavir/ritonavir (24 patients) or nevirapine (21 children).
Results: Using both antiretroviral therapy schemes leads to suppression of HIV replication, improvement of clinical and immunological parameters. However, the treatment with lopinavir/ritonavir revealed a significant positive changes of HIV blood viral load, immune status and clinical picture. Testing of clinical and laboratory parameters prior to treatment in the Cox hazard model showed that the independent predictor of prolonging the effectiveness of therapy is the lopinavir/ritonavir use. As a side effect of lopinavir/ritonavir developed dyspeptic symptoms.
Conclusion: High efficiency and safety of lopinavir/ritonavir allow us to recommend the inclusion of this drug in the selection schemes of antiretroviral therapy in HIV infected children.
About the Authors
V. B. Denisenko
Rostov State Medical University
Russian Federation
Russian Federation
Valentin Denisenko, PhD, Associate Professor of the Department of Children Infectious Diseases
Rostov-on-Don
E. N. Simovanyan
Rostov State Medical University
Russian Federation
Russian Federation
Emma Simovanyan, MD, Professor, Head of the Department of Children Infectious Diseases
Rostov-on-Don
References
1. Rakhmanova A.G., Voronin E.E., Fomin Yu.A. HIV infection in children. St. Petersburg: Foliant, 2003: 440. (In Russ.)
2. Timchenko V.N., Jastrebova E.B., Bulina O.V. Perinatal HIV infection in St. Petersburg and modern therapy of concomitant viral infections. Detskie Infektsii=Children's Infections. 2016; 15(1):24—29. (In Russ.)
3. Voronin E.E., Afonina L.Ju., Latysheva I.B. et al. HIV infection in children. Clinical recommendations. Мoscow, 2017: 34. (In Russ.)
4. Bartlett D., Gallant D., Fam P. Clinical aspects of HIV infection. Мoscow.: R. Valent, 2012: 528. (In Russ.)
5. Denisenko V.B., Simovanyan E.N., Beketova E.V. Experience with the use of viral protease inhibitors in children with HIV infection. Pediatricheskaja Farmakologija=Pediatric Pharmacology. 2010. 1: 62—67. (In Russ.)
6. Antiretroviral therapy for HIV infection in infants and children: towards universal access. — Geneva: World Health Organization (WHO), 2010:10 р.
7. Hofman K., Rokshtro Ju.K. Treatment of HIV infection-2011. Мoscow.: R. Valent, 2012: 736. (In Russ.)
Review
For citations:
Denisenko V.B., Simovanyan E.N. IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION. CHILDREN INFECTIONS. 2018;17(2):34-39. (In Russ.) https://doi.org/10.22627/2072-8107-2018-17-2-34-39
Views:
830
Email this article 